Form N-14 8C Franklin BSP Capital
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260518/AB2J922CLZ224J6Z2IJN2ZY2AC9QZ222Z282
Filed on: May 18, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
- Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
- Luxel Corporation Appoints KOS, Inc. as Exclusive Distributor in South Korea
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
